Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill S Dolinsky

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Genetics|October 19, 2016
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriersTracey P Leedom, Holly LaDuca, Rachel McFarland, et al.
JNCI Cancer Spectrum|May 23, 2022
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management RecommendationsCarolyn Horton, Kirsten Blanco, Min-Tzu Lo, et al.
Gynecologic Oncology|January 28, 2015
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2Lindsey E Minion, Jill S Dolinsky, Dana M Chase, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Quality of Clinician-Reported Cancer History When Ordering Genetic TestingHolly LaDuca, Rachel McFarland, Stephanie Gutierrez, et al.
Journal of the National Cancer Institute|March 13, 2018
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based TestingHuma Q Rana, Rebecca Gelman, Holly LaDuca, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Breast Cancer Research and Treatment|December 24, 2016
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsMary Pritzlaff, Pia Summerour, Rachel McFarland, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2019
Genotype-phenotype associations among panel-based TP53+ subjectsHuma Q Rana, Jacob Clifford, Lily Hoang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2017
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarSteven M Harrison, Jill S Dolinsky, Amy E Knight Johnson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 23, 2020
Diagnosing hereditary cancer predisposition in men with prostate cancerMary Pritzlaff, Yuan Tian, Patrick Reineke, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Genetics|October 19, 2016
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriersTracey P Leedom, Holly LaDuca, Rachel McFarland, et al.
JNCI Cancer Spectrum|May 23, 2022
Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management RecommendationsCarolyn Horton, Kirsten Blanco, Min-Tzu Lo, et al.
Gynecologic Oncology|January 28, 2015
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2Lindsey E Minion, Jill S Dolinsky, Dana M Chase, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Quality of Clinician-Reported Cancer History When Ordering Genetic TestingHolly LaDuca, Rachel McFarland, Stephanie Gutierrez, et al.
Journal of the National Cancer Institute|March 13, 2018
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based TestingHuma Q Rana, Rebecca Gelman, Holly LaDuca, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Breast Cancer Research and Treatment|December 24, 2016
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected resultsMary Pritzlaff, Pia Summerour, Rachel McFarland, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2019
Genotype-phenotype associations among panel-based TP53+ subjectsHuma Q Rana, Jacob Clifford, Lily Hoang, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2017
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarSteven M Harrison, Jill S Dolinsky, Amy E Knight Johnson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 23, 2020
Diagnosing hereditary cancer predisposition in men with prostate cancerMary Pritzlaff, Yuan Tian, Patrick Reineke, et al.
Pageof 4